Document is current
Any future updates will be listed below
-
Authors
Tahk, Siret
Vick, Binje
Hiller, Björn
Schmitt, Saskia
Marcinek, Anetta
Perini, Enrico D.
Leutbecher, Alexandra
Augsberger, Christian
Reischer, Anna
Tast, Benjamin
Humpe, Andreas
Jeremias, Irmela
Subklewe, Marion
Fenn, Nadja C.
Hopfner, Karl-Peter https://orcid.org/0000-0002-4528-8357
-
Funding
Funding for this research was provided by:
H2020 Marie Skłodowska-Curie Actions (641549)
Deutsche Forschungsgemeinschaft
Elitenetzwerk Bayern
bundesministerium für wirtschaft und energie (Exist Transfer of Research I grant)
Ludwig-Maximilians-Universität München
- License Information
-
More Information
Article History
Received: 5 March 2021
Accepted: 7 September 2021
First Online: 27 September 2021
Declarations
:
: After obtaining written informed consent in accordance with the Declaration of Helsinki and approval by the Institutional Review Board of the Ludwig-Maximilians-Universität, peripheral blood, bone marrow or leukoreduction material was collected from AML patients and healthy donors. All animal studies were performed in accordance with the current ethical standards of the official committee on animal experimentation (written approval by Regierung von Oberbayern, ROB-55.2Vet-2532. Vet_02-16–7 and ROB-55.2Vet-2532.Vet_03-16–56).
: Not applicable.
: KPH, MS and NCF are inventors of a patent application regarding the SIRPα-antibody fusion proteins.
